Efficacy and safety of 7-day aerosolized epigallocatechin-3-gallate in oncologic patients with COVID-19 pneumonia.
- 2026-01-19
- RCT · n = 114
- BMC cancer 26(1)
- Wanqi Zhu
- Li Jia
- Qiang Qiao
- Xiaolin Li
- Xie Peng
- Xiangjiao Meng
- Lingling Kong
- Hanxi Zhao
- PubMed: 41549240
- DOI: 10.1186/s12885-026-15553-x
- High evidence
- Large Human Trial
- Clinical
Post-treatment lactate dehydrogenase levels were significantly lower in the EGCG group (P = 0.028)
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes